Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 3 Acute Kidney Injury”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Ended earlyNCT04411472
What this trial is testing

(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

Who this might be right for
Acute Kidney Injury Due to Sepsis
AM-Pharma 676
Not applicableActive Not RecruitingNCT06254703
What this trial is testing

Venous Excess and Lung Ultrasound During Continuous Kidney Replacement Therapy in Critically Ill Patients

Who this might be right for
Acute Kidney Failure Stage 3
Chulalongkorn University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05746559
What this trial is testing

ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

Who this might be right for
Chronic Kidney DiseaseCKDCardiac Disease+1 more
Alexion Pharmaceuticals, Inc. 736
Not applicableUnknownNCT02937935
What this trial is testing

On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With Cirrhosis

Who this might be right for
Acute Kidney Injury With Cirrhosis
Institute of Liver and Biliary Sciences, India 2
Not applicableStudy completedNCT04622384
What this trial is testing

The Performance of Renal Doppler Ultrasound in Predicting Outcome of Dialysis Weaning

Who this might be right for
Acute Kidney InjuryAcute Kidney Failure Stage 3
Johan Fridolf Hermansen 33
Not applicableNot Yet RecruitingNCT06760650
What this trial is testing

Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 4Chronic Kidney Disease Stage 3BChronic Kidney Disease Stage 5+3 more
Saint-Joseph University 35
Large-scale testing (Phase 3)UnknownNCT02474667
What this trial is testing

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Who this might be right for
Delayed Graft Function
Angion Biomedica Corp 253
Early research (Phase 1)Study completedNCT02248051
What this trial is testing

Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury

Who this might be right for
Acute Kidney Injury (Nontraumatic)
Complexa, Inc. 12
Not applicableStudy completedNCT04172103
What this trial is testing

The Association Between the Duration of Acute Kidney Injury and New-onset Chronic Kidney Disease After Cardiac or Thoracic Aortic Surgery

Who this might be right for
Acute Kidney InjuryChronic Kidney Disease, Stage 3Chronic Kidney Disease, Stage 5+2 more
Seoul National University Hospital 2,009
Large-scale testing (Phase 3)Ended earlyNCT04743804
What this trial is testing

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Who this might be right for
Thrombotic Microangiopathy
Alexion Pharmaceuticals, Inc. 16
Large-scale testing (Phase 3)Study completedNCT00416897
What this trial is testing

Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmRenal Failure
University of Glasgow 280
Not applicableStudy completedNCT06036758
What this trial is testing

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

Who this might be right for
Acute Kidney InjuryStage 2 Acute Kidney InjuryStage 3 Acute Kidney Injury
BioMérieux 477
Large-scale testing (Phase 3)Active Not RecruitingNCT05815485
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia

Who this might be right for
COVID-19
The University of Texas Medical Branch, Galveston 144
Not applicableLooking for participantsNCT06150742
What this trial is testing

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

Who this might be right for
Acute Kidney Injury
Talphera, Inc 70
Not applicableStudy completedNCT05264584
What this trial is testing

Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3

Who this might be right for
Chronic Kidney Disease stage3Contrast-induced Nephropathy
Ain Shams University 120
Large-scale testing (Phase 3)Ended earlyNCT03510897
What this trial is testing

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Who this might be right for
Cardiac Surgery
Quark Pharmaceuticals 1,043
Large-scale testing (Phase 3)Ended earlyNCT03403751
What this trial is testing

Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury

Who this might be right for
Acute Kidney InjuryPeritonitisNecrotizing Soft Tissue Infection
Atox Bio Ltd 58
Post-approval studies (Phase 4)Ended earlyNCT02467075
What this trial is testing

Double-Blind Placebo-Controlled CIN Trial

Who this might be right for
Acute Kidney Injury
University of Michigan 1
Post-approval studies (Phase 4)Ended earlyNCT03119662
What this trial is testing

Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Diseases
GE Healthcare 4
Early research (Phase 1)Active Not RecruitingNCT05360615
What this trial is testing

The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

Who this might be right for
Empagliflozin in Post AKI Stage 2-3
Chulalongkorn University 147